Structure-based engineering of internal cavities in coiled-coil peptides.
Structure-based engineering of internal cavities in coiled-coil peptides.
复制标题
卷曲螺旋肽内腔的基于结构的工程。
DOI:
10.1021/bi050742a
复制
发表时间:
2005
期刊:
影响因子:
2.9
通讯作者:
Ghadiri,MReza
中科院分区:
文献类型:
--
作者:
Yadav,ManeeshK;Redman,JamesE;Leman,LukeJ;Alvarez-Gutiérrez,JuliettaM;Zhang,Yanming;Stout,CDavid;Ghadiri,MReza
Cavities and clefts are frequently important sites of interaction between natural enzymes or receptors and their corresponding substrate or ligand molecules and exemplify the types of molecular surfaces that would facilitate engineering of artificial catalysts and receptors. Even so, structural characterizations of designed cavities are rare. To address this issue, we performed a systematic study of the structural effects of single-amino acid substitutions within the hydrophobic cores of tetrameric coiled-coil peptides. Peptides containing single glycine, serine, alanine, or threonine amino acid substitutions at the buried L9, L16, L23, and I26 hydrophobic core positions of a GCN4-based sequence were synthesized and studied by solution-phase and crystallographic techniques. All peptides adopt the expected tetrameric state and contain tunnels or internal cavities ranging in size from 80 to 370 Å3. Two closely related sequences containing an L16G substitution, one of which adopts an antiparallel configuration and one of which adopts a parallel configuration, illustrate that cavities of different volumes and shapes can be engineered from identical core substitutions. Finally, we demonstrate that two of the peptides (L9G and L9A) bind the small molecule iodobenzene when present during crystallization, leaving the general peptide quaternary structure intact but altering the local peptide conformation and certain superhelical parameters. These high-resolution descriptions of varied molecular surfaces within solvent-occluded internal cavities illustrate the breadth of design space available in even closely related peptides and offer valuable models for the engineering of de novo helical proteins.